These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36496010)

  • 1. Prothymosin α-derived hexapeptide prevents the brain damage and sequelae due to ischemia-hemorrhage.
    Ueda H
    Peptides; 2023 Feb; 160():170922. PubMed ID: 36496010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prothymosin alpha and its mimetic hexapeptide improve delayed tissue plasminogen activator-induced brain damage following cerebral ischemia.
    Halder SK; Matsunaga H; Ueda H
    J Neurochem; 2020 Jun; 153(6):772-789. PubMed ID: 31454420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial actions of prothymosin alpha-mimetic hexapeptide on central post-stroke pain, reduced social activity, learning-deficit and depression following cerebral ischemia in mice.
    Sasaki K; Halder SK; Matsunaga H; Ueda H
    Peptides; 2020 Apr; 126():170265. PubMed ID: 31982448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hexapeptide derived from prothymosin alpha attenuates cisplatin-induced acute kidney injury.
    Torigoe K; Obata Y; Torigoe M; Oka S; Yamamoto K; Koji T; Ueda H; Mukae H; Nishino T
    Clin Exp Nephrol; 2020 May; 24(5):411-419. PubMed ID: 31912273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective impact of prothymosin alpha-derived hexapeptide against retinal ischemia-reperfusion.
    Ueda H; Halder SK; Matsunaga H; Sasaki K; Maeda S
    Neuroscience; 2016 Mar; 318():206-18. PubMed ID: 26779836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prothymosinα, as a neuroprotective DAMPs/Alarmins molecule].
    Ueda H; Maeda S
    Nihon Yakurigaku Zasshi; 2018; 151(1):15-19. PubMed ID: 29321391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prothymosin α Plays Role as a Brain Guardian through Ecto-F
    Ueda H
    Cells; 2023 Feb; 12(3):. PubMed ID: 36766838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prothymosin alpha and cell death mode switch, a novel target for the prevention of cerebral ischemia-induced damage.
    Ueda H
    Pharmacol Ther; 2009 Sep; 123(3):323-33. PubMed ID: 19500618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoflurane preconditioning inhibits the effects of tissue-type plasminogen activator on brain endothelial cell in an
    Cheon SY; Kim SY; Kam EH; Lee JH; Kim JM; Kim EJ; Kim TW; Koo BN
    Int J Med Sci; 2017; 14(5):425-433. PubMed ID: 28539818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prothymosin alpha plays a key role in cell death mode-switch, a new concept for neuroprotective mechanisms in stroke.
    Ueda H
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Jun; 377(4-6):315-23. PubMed ID: 18176798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prothymosin-alpha plays a defensive role in retinal ischemia through necrosis and apoptosis inhibition.
    Fujita R; Ueda M; Fujiwara K; Ueda H
    Cell Death Differ; 2009 Feb; 16(2):349-58. PubMed ID: 18989338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prothymosin alpha as robustness molecule against ischemic stress to brain and retina.
    Ueda H; Matsunaga H; Uchida H; Ueda M
    Ann N Y Acad Sci; 2010 Apr; 1194():20-6. PubMed ID: 20536446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix Metalloproteinase-9 Expression is Enhanced by Ischemia and Tissue Plasminogen Activator and Induces Hemorrhage, Disability and Mortality in Experimental Stroke.
    Saleem S; Wang D; Zhao T; Sullivan RD; Reed GL
    Neuroscience; 2021 Apr; 460():120-129. PubMed ID: 33465414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of tissue plasminogen activator-induced hemorrhage and brain injury by free radical spin trapping after embolic focal cerebral ischemia in rats.
    Asahi M; Asahi K; Wang X; Lo EH
    J Cereb Blood Flow Metab; 2000 Mar; 20(3):452-7. PubMed ID: 10724108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normobaric hyperoxia reduces the neurovascular complications associated with delayed tissue plasminogen activator treatment in a rat model of focal cerebral ischemia.
    Liu W; Hendren J; Qin XJ; Liu KJ
    Stroke; 2009 Jul; 40(7):2526-31. PubMed ID: 19478225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of tissue plasminogen activator on cerebral microvessels of rats during focal cerebral ischemia and reperfusion.
    Yang DY; Pan HC; Chen CJ; Cheng FC; Wang YC
    Neurol Res; 2007 Apr; 29(3):274-82. PubMed ID: 17509227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia.
    Tsuji K; Aoki T; Tejima E; Arai K; Lee SR; Atochin DN; Huang PL; Wang X; Montaner J; Lo EH
    Stroke; 2005 Sep; 36(9):1954-9. PubMed ID: 16051896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Quinazoline Otaplimastat (SP-8203) Reduces the Hemorrhagic Transformation and Mortality Aggravated after Delayed rtPA-Induced Thrombolysis in Cerebral Ischemia.
    Song HY; Chung JI; Jalin AMA; Ju C; Pahk K; Joung C; Lee S; Jin S; Kim BS; Lee KS; Ryu JM; Kim WK
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prothymosin-alpha preconditioning activates TLR4-TRIF signaling to induce protection of ischemic retina.
    Halder SK; Matsunaga H; Ishii KJ; Ueda H
    J Neurochem; 2015 Dec; 135(6):1161-77. PubMed ID: 26364961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lysophosphatidic Acid Receptor Signaling Underlying Chronic Pain and Neuroprotective Mechanisms through Prothymosin α].
    Ueda H
    Yakugaku Zasshi; 2019; 139(11):1403-1415. PubMed ID: 31685737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.